Nicola Pavese Selected Research

PK 11195 (PK11195)

1/2019	New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease.
5/2014	Brain shaving: adaptive detection for brain PET data.
4/2011	Global-two-stage filtering of clinical PET parametric maps: application to [(11)C]-(R)-PK11195.
12/2008	Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.
5/2007	A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195.
2/2006	In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola Pavese Research Topics

Disease

48	Parkinson Disease (Parkinson's Disease) 01/2022 - 07/2002
12	Parkinsonian Disorders (Parkinsonism) 01/2021 - 10/2002
9	Neuroinflammatory Diseases 01/2021 - 04/2011
9	Huntington Disease (Huntington's Disease) 12/2018 - 05/2003
6	Tremor (Tremors) 01/2021 - 12/2005
5	Dyskinesias (Dyskinesia) 04/2011 - 07/2002
4	Disease Progression 01/2022 - 07/2009
4	Cognitive Dysfunction 10/2021 - 07/2017
3	Disorders of Excessive Somnolence (Hypersomnia) 01/2020 - 10/2015
3	Inflammation (Inflammations) 12/2018 - 01/2012
3	Fatigue 10/2015 - 01/2010
2	REM Sleep Behavior Disorder 10/2021 - 12/2020
2	Hypokinesia (Bradykinesia) 01/2020 - 01/2012
2	Alzheimer Disease (Alzheimer's Disease) 07/2017 - 12/2008
2	Movement Disorders (Movement Disorder) 01/2017 - 07/2012
2	Essential Tremor (Essential Tremors) 01/2017 - 01/2014
2	Dystonia (Limb Dystonia) 01/2016 - 12/2005
1	Brain Diseases (Brain Disorder) 01/2022
1	Olfaction Disorders (Cacosmia) 10/2021
1	Kuru 03/2019
1	Cerebral Infarction 01/2019
1	Multiple Sclerosis 01/2019
1	Wallerian Degeneration 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2018
1	Encephalitis (Encephalitis, Rasmussen) 07/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2016
1	Hepatolenticular Degeneration (Wilson's Disease) 01/2016
1	HIV Infections (HIV Infection) 01/2014
1	Hyperammonemia 08/2013
1	Atrophy 06/2013
1	Autonomic Nervous System Diseases (Dysautonomia) 01/2010
1	Dementia (Dementias) 01/2010
1	Sleep Wake Disorders 01/2010
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 10/2009
1	Psychotic Disorders (Schizoaffective Disorder) 10/2009
1	Fibrosis (Cirrhosis) 10/2007

Drug/Important Bio-Agent (IBA)

19	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 10/2002
9	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 07/2004
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2009
6	PK 11195 (PK11195)IBA 01/2019 - 02/2006
4	neuromelaninIBA 01/2022 - 01/2018
4	Cholinergic Agents (Cholinergics)IBA 10/2021 - 01/2010
4	SynucleinsIBA 10/2020 - 03/2015
4	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2020 - 11/2010
4	RacloprideIBA 01/2017 - 06/2004
4	Dihydroxyphenylalanine (Dopa)IBA 09/2013 - 10/2002
4	Dopamine Agonists (Dopamine Agonist)IBA 10/2007 - 07/2004
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 04/2012
3	AcetylcholinesteraseIBA 12/2020 - 03/2015
3	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2020 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2014
3	IronIBA 03/2018 - 07/2009
3	Dopamine Receptors (Dopamine Receptor)IBA 12/2016 - 05/2003
3	Methamphetamine (Desoxyn)FDA LinkGeneric 12/2005 - 05/2003
2	Pharmaceutical PreparationsIBA 01/2022 - 10/2015
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 07/2017 - 12/2008
2	Serotonin (5 Hydroxytryptamine)IBA 04/2012 - 11/2010
2	fluorodopa F 18IBA 01/2012 - 11/2009
1	opicaponeIBA 01/2022
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	CytokinesIBA 11/2020
1	Pattern Recognition ReceptorsIBA 11/2020
1	PrionsIBA 10/2020
1	Prion ProteinsIBA 03/2019
1	RadiopharmaceuticalsIBA 01/2019
1	SuspensionsIBA 12/2018
1	Mutant Proteins (Protein, Mutant)IBA 12/2018
1	rotigotine FDA Link 06/2018
1	Carbidopa (Lodosyn)FDA LinkGeneric 01/2017
1	Dopamine D3 ReceptorsIBA 12/2016
1	naxagolideIBA 12/2016
1	Donepezil (Aricept)FDA LinkGeneric 03/2015
1	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 01/2014
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 09/2013
1	AmmoniaIBA 08/2013
1	Inositol (Myoinositol)IBA 01/2012
1	CreatineIBA 01/2012
1	Ion Channels (Ion Channel)IBA 04/2011
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2011
1	Glutamic Acid (Glutamate)FDA Link 04/2011
1	Cyanamide (Calcium Carbimide)IBA 04/2011
1	benzylamineIBA 11/2010
1	Neuroprotective AgentsIBA 12/2009
1	LigandsIBA 11/2008
1	NeuropeptidesIBA 11/2008
1	Apomorphine FDA Link 10/2007
1	Pergolide (Permax)FDA Link 10/2007
1	Cabergoline FDA LinkGeneric 10/2007
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 06/2006
1	Dopamine Agents (Dopaminergic Agents)IBA 05/2006

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2006
10	Deep Brain Stimulation 01/2022 - 07/2012
5	Denervation 01/2022 - 01/2012
4	Transplantation 12/2018 - 07/2002
2	Cell Transplantation 12/2018 - 06/2013
1	Investigational Therapies (Experimental Therapy) 01/2018
1	Parasympathectomy 03/2015